Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun ...

Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Checkpoint Therapeutics, Inc., a ...

India’s Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a US-based immunotherapy and ...

Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture ...

Sun Pharmaceutical Industries said that it has entered into an agreement for the acquisition of all the outstanding shares of Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology ...

Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company.

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...

West Virginia lawmakers have made history by passing a groundbreaking bill that bans a slate of artificial food dyes and preservatives, positioning the ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Interest in human use of ivermectin grew when people began taking it to prevent or treat COVID-19, despite the FDA and other ...

Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...